In addition, emerging evidence indicates that NSAIDs, in particular aspirin, given as adjuvant therapy improve CRC overall survival, especially for patients with high PTGS2 (COX-2) expression (7, 8). Here, PTGS2 is linked to colorectal carcinoma.